Back

Sex-specific maturational trajectory of endocannabinoid plasticity in the rat prefrontal cortex

Bernabeu, A.; Bara, A.; Manduca, A.; Borsoi, M.; Lassalle, O.; Pelissier-Alicot, A.-L.; MANZONI, O. J.

2020-10-10 neuroscience
10.1101/2020.10.09.332965 bioRxiv
Show abstract

The prefrontal cortex (PFC) develops until early adulthood in rodents and humans, but how synaptic plasticity evolves throughout postnatal development is not known. Here, we used a cross-sectional approach to establish the postnatal maturational trajectories of intrinsic properties and synaptic plasticity in the PFC of rats of both sexes. We found that while layer 5 PFC pyramidal neurons from rats of both sexes displayed similar current-voltage relationships, rheobases and resting potentials across all age groups, excitability was lower in female adults compared to the other developmental stages. NMDAR-dependent long-term potentiation and mGluR2/3-mediated long-term depression (LTD) were equally expressed at the juvenile, pubescent and adult developmental stages in animals of both sexes. However, the developmental course of endocannabinoid (eCB)-mediated LTD was sexually dimorphic. First, eCB-LTD emerged during the juvenile period in females. However, although CB1Rs were functional in both sexes at all developmental stages, eCB-LTDs first emerged during pubescence in male. Second, eCB-LTD engaged distinct receptors in males and females depending on their developmental stages. Female rats employ both CB1R and TRPV1R to produce eCB-LTD at the juvenile stage but solely CB1R at pubescence followed by only TRPV1R at adulthood. In contrast, in pubescent and adult males eCB-LTD always and exclusively depended on CB1R. Pharmacological blockade of 2AGs principal degrading enzyme allowed incompetent male juvenile synapses to express eCB-LTD. The data reveal different maturational trajectories in the PFC of male and female rats and provide new cellular substrates to the sex-specific behavioral and synaptic abnormalities caused by adolescent exposure to cannabinoids.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Neuropharmacology
68 papers in training set
Top 0.1%
30.8%
2
The Journal of Neuroscience
1025 papers in training set
Top 2%
9.7%
3
eneuro
439 papers in training set
Top 0.6%
7.2%
4
eLife
5828 papers in training set
Top 17%
6.7%
50% of probability mass above
5
Journal of Neurophysiology
302 papers in training set
Top 1%
3.2%
6
The Journal of Physiology
150 papers in training set
Top 0.9%
2.4%
7
Neuropsychopharmacology
153 papers in training set
Top 1%
2.1%
8
Brain Structure and Function
93 papers in training set
Top 0.5%
2.1%
9
Neurobiology of Stress
43 papers in training set
Top 0.3%
1.9%
10
Neuroscience
97 papers in training set
Top 0.7%
1.9%
11
Cerebral Cortex
396 papers in training set
Top 3%
1.7%
12
Frontiers in Cellular Neuroscience
91 papers in training set
Top 1%
1.5%
13
Psychopharmacology
69 papers in training set
Top 0.5%
1.5%
14
Scientific Reports
3612 papers in training set
Top 60%
1.4%
15
Translational Psychiatry
260 papers in training set
Top 3%
1.4%
16
Molecular Psychiatry
282 papers in training set
Top 4%
1.3%
17
Developmental Cognitive Neuroscience
96 papers in training set
Top 0.9%
1.1%
18
Biological Psychiatry
137 papers in training set
Top 2%
1.0%
19
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.9%
1.0%
20
Cell Reports
1498 papers in training set
Top 26%
1.0%
21
Journal of Neurochemistry
53 papers in training set
Top 1%
0.8%
22
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.7%
0.8%
23
iScience
1154 papers in training set
Top 35%
0.8%
24
Nature Communications
5641 papers in training set
Top 60%
0.6%
25
Frontiers in Synaptic Neuroscience
17 papers in training set
Top 0.3%
0.6%
26
Brain Research
38 papers in training set
Top 1%
0.6%
27
European Journal of Neuroscience
189 papers in training set
Top 4%
0.6%
28
Frontiers in Neuroscience
256 papers in training set
Top 7%
0.6%